Clinical Trial Update: Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

Phase 1 trial of dimethyl fumarate in systemic sclerosis-associated pulmonary arterial hypertension has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Robert Lafyatis | Conditions: Systemic Sclerosis, Pulmonary; Hypertension | Phase 1 | Status: TERMINATED | Results posted: 2022-03-17